STENTIT raises €12,5M EIC Accelerator

Venture Challenge alumnus Stentit has successfully raised €12.5M in funding from the EIC Accelerator. The Money will be used for the first clinical trials with patients at risk of leg amputation, and to introduce our regenerative stents to the medical market. 

"It's so rewarding to witness such a support by the European Commission and see our proposal being chosen among the more than 500 submissions. This pays off for years of hard work and it gives us new energies for the work ahead of us. This recognition is not just for our team, but also the people out there who have been trusting us for all this time and, most importantly, all our patients"

comment CEO Bart Sanders and COO Golo von Basum.